Reducing Disparities in Late Life Depression and Metabolic Syndrome (BRIGHTEN-Heart)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Linkages between depression and cardiovascular disease have been well documented. These appear to be more than associations, and may reflect causal relationships through a number of proposed pathways, including decreased physical activity, poor dietary habits, medication non-adherence, and a direct impact on inflammatory mediators. Older adults are affected by both depression and heart disease, with increased risk in African American and Latino elderly.
The BRIGHTEN-Heart trial tests the hypothesis that an enhanced primary care delivery system intervention which provides evidence-based, patient-centered mental health services targeting depression and cardiovascular risk factors can reduce the risk of development of cardiovascular disease in low-income elderly blacks and Hispanics. BRIGHTEN stands for Bridging Resources of a Geriatric Health Team via Electronic Networking, and in this intervention, specialty providers including geropsychologists, social workers, pharmacists, nutritionists, chaplains, occupational therapists, and others collaborate via the internet as a virtual team. The study will determine if such a virtual interdisciplinary clinical team collaboration can reduce depression in older (age ≥ 65) minority adults with comorbid depression and metabolic syndrome.
| Condition | Intervention |
|---|---|
|
Depressive Symptoms Metabolic Syndrome X Overweight Obesity Hypertension Hyperglycemia Dyslipidemias |
Behavioral: Generations older adult membership program Behavioral: BRIGHTEN Heart Virtual Team intervention |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome |
- Clinical Depression Scores, as measured by PHQ-9 [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]Depression has been shown to double both the risk of developing heart disease and mortality risk for persons who do develop heart disease. The Primary Aim of the trial is to document reduction in symptoms of depression in persons receiving the intervention, relative to the control group. The PHQ-9 instrument is the most widely used symptom measure of depression, and has been validated across multiple populations, and in a Spanish-translation as well
- Cardiometabolic risk factors [ Time Frame: 6 months ] [ Designated as safety issue: No ]Risk for the development of heart disease will be compared via clinical measures and blood tests. Clinical measurements include Blood Pressure, Weight, and Waist Circumference. Blood tests include Hemoglobin A1c, HDL Cholesterol, LDL Cholesterol, and hsCRP.
| Estimated Enrollment: | 250 |
| Study Start Date: | March 2011 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | March 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Generations older adult membership program
Rush Generations is a membership program for older adults, providing chronic disease prevention and management through educational programming, civic engagement, and individual and family consultations with social work staff.
|
Behavioral: Generations older adult membership program
Rush Generations is a membership program for older adults emphasizing chronic disease prevention and management through a wide range of health and aging-related programs. Participants assigned to the Generations intervention are actively encouraged to participate in activities, including:
|
|
Experimental: BRIGHTEN Heart Virtual Team
BRIGHTEN Heart provides older adults with an interdisciplinary team evaluation of physical and mental health and on-going support for mental health and health behavior change for a minimum of six months. The five core components of the BRIGHTEN intervention consist of: 1) Assessment; 2) Virtual team case review; 3) Patient centered action planning; 4) Plan implementation, and; 5) When indicated, short-term evidence-based geriatric specialty psychotherapy.
|
Behavioral: BRIGHTEN Heart Virtual Team intervention
BRIGHTEN Heart provides an interdisciplinary team evaluation of physical and mental health and on-going support for mental health & health behavior change for 6 - 12 months, including:
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 60 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- At least 60 years of age.
- Overweight or Obese as documented by BMI greater than 25.0.
- Presence of Depression symptoms, as determined by having a PHQ-9 score of 8 or more.
- Receiving primary care through a participating safety net clinic (public clinic or FQHC)
Exclusion Criteria:
- Below the age of 60 years old at time of enrollment.
- Lack decisional capacity (due to dementia, active psychosis, or other cause).
- Are currently under active behavioral treatment of a psychologist or psychiatrist for any reason.
- Lack regular access to a telephone in their home (including cell phone).
- Are enrolled in another intervention trial
Contacts and Locations| Contact: Steven K Rothschild, MD | 312 942 3476 | steven_k_rothschild@rush.edu |
| Contact: Erin Emery, PhD | 312 942 6294 | erin_emery@rush.edu |
| United States, Illinois | |
| Cook County Health and Hospital System | Recruiting |
| Chicago, Illinois, United States | |
| Resurrection Medical Center | Recruiting |
| Chicago, Illinois, United States | |
| Principal Investigator: | Steven K Rothschild, MD | Department of Preventive Medicine, Rush University Medical Center |
| Principal Investigator: | Erin Emery, PhD | Department of Behavioral Sciences, Rush University Medical Center |
More Information
No publications provided
| Responsible Party: | Steven K. Rothschild, MD, MD, Rush University Medical Center |
| ClinicalTrials.gov Identifier: | NCT01428791 History of Changes |
| Other Study ID Numbers: | 1P50 HL105189-01 |
| Study First Received: | September 1, 2011 |
| Last Updated: | September 24, 2012 |
| Health Authority: | United States: National Heart Lung and Blood Institute |
Keywords provided by Rush University Medical Center:
|
Geriatrics Older adults Health Disparities Health Services for the Aged Interdisciplinary Health Team Depressive symptoms |
Metabolic Syndrome X Overweight Obesity Hypertension Hyperglycemia Dyslipidemias |
Additional relevant MeSH terms:
|
Depression Depressive Disorder Hyperglycemia Hypertension Obesity Dyslipidemias Overweight Metabolic Syndrome X Behavioral Symptoms Mood Disorders Mental Disorders |
Glucose Metabolism Disorders Metabolic Diseases Vascular Diseases Cardiovascular Diseases Overnutrition Nutrition Disorders Body Weight Signs and Symptoms Lipid Metabolism Disorders Insulin Resistance Hyperinsulinism |
ClinicalTrials.gov processed this record on May 23, 2013